Plasma exchange versus intravenous immunoglobulin treatment in myasthenic crisis.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 10025801.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We performed a retrospective multicenter chart review to compare the efficacy and tolerance of plasma exchange (PE) and intravenous immunoglobulin (i.v.Ig) in treatment of 54 episodes of myasthenic crisis. After adjustment for other variables, PE (compared with i.v.Ig) was associated with a superior ventilatory status at 2 weeks (partial F = 6.2, p = 0.02) and 1 month functional outcome (partial F = 4.5, p = 0.04). However, the complication rate was higher with PE compared with i.v.Ig (13 versus 5 episodes, p = 0.07).
Medical subject headings
- Immunoglobulins, Intravenous
- Myasthenia Gravis
- Plasma Exchange